Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Eurofins Scientific SE    ERF   FR0014000MR3

EUROFINS SCIENTIFIC SE

(ERF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eurofins Scientific SE : No turn-around in sight

09/29/2020 | 04:56am EST
long trade
Target price hit
Entry price : 675.4€ | Target : 728.2€ | Stop-loss : 640.7€ | Potential : 7.82%
The underlying tendency is to the upside for shares in Eurofins Scientific SE and the timing is opportune to get back into the stock. A comeback of the upward dynamic can be anticipated.
Investors have an opportunity to buy the stock and target the € 728.2.
Eurofins Scientific SE : Eurofins Scientific SE : No turn-around in sight
Strengths
  • Historically, the company has been releasing figures that are above expectations.
  • The stock is in a well-established, long-term rising trend above the technical support level at 536 EUR

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at EUR 699.4.
  • The company is in debt and has limited leeway for investment
  • The firm trades with high earnings multiples: 40.51 times its 2020 earnings per share.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

© MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2020 5 379 M 6 514 M 6 514 M
Net income 2020 411 M 497 M 497 M
Net Debt 2020 2 812 M 3 405 M 3 405 M
P/E ratio 2020 36,7x
Yield 2020 0,66%
Capitalization 14 916 M 18 089 M 18 065 M
EV / Sales 2020 3,30x
EV / Sales 2021 3,09x
Nbr of Employees 48 000
Free-Float 66,7%
Upcoming event on EUROFINS SCIENTIFIC SE
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 74,29 €
Last Close Price 78,18 €
Spread / Highest target 8,85%
Spread / Average Target -4,98%
Spread / Lowest Target -51,1%
EPS Revisions
Managers and Directors
NameTitle
Gilles J. Martin Chairman & Chief Executive Officer
Laurent Lebras Director-Group Finance & Administration
Andreas König Chief Information Officer
Yves-Loïc Martin Non-Executive Director
Valérie Hanote Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
EUROFINS SCIENTIFIC SE13.92%18 089
SQUARE, INC.-0.46%97 691
FISERV, INC.-6.28%71 542
GLOBAL PAYMENTS INC.-14.08%55 401
OFFCN EDUCATION TECHNOLOGY CO., LTD.8.77%36 367
CINTAS CORPORATION-7.17%34 463